Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Parodis

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|January 21, 2022
Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?Ioannis Parodis, Paul Studenic
Annals of the Rheumatic Diseases|September 15, 2021
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?Ioannis Parodis, Frederic A Houssiau
Frontiers in Medicine|September 16, 2022
B cells in systemic lupus erythematosus: Targets of new therapies and surveillance toolsIoannis Parodis, Mariele Gatto, Christopher Sjöwall
The Journal of Rheumatology|November 15, 2023
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus ErythematosusZahi Touma, Ioannis Parodis, Vibeke Strand
Current Opinion in Rheumatology|January 11, 2022
Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insightsJulius Lindblom, Chandra Mohan, Ioannis Parodis
Rheumatology (Oxford, England)|January 12, 2024
Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumabSandra Jägerback, Alvaro Gomez, Ioannis Parodis
Brain Sciences|February 25, 2022
Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last DecadeJulius Lindblom, Chandra Mohan, Ioannis Parodis
Frontiers in Medicine|August 6, 2020
B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical PracticeIoannis Parodis, Marit Stockfelt, Christopher Sjöwall
Patient Related Outcome Measures|January 26, 2023
Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World EvidenceAlvaro Gomez, Yvonne Enman, Ioannis Parodis
Rheumatology International|March 7, 2024
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional studyAlvaro Gomez, Ioannis Parodis, Christopher Sjöwall
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|January 21, 2022
Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?Ioannis Parodis, Paul Studenic
Annals of the Rheumatic Diseases|September 15, 2021
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?Ioannis Parodis, Frederic A Houssiau
Frontiers in Medicine|September 16, 2022
B cells in systemic lupus erythematosus: Targets of new therapies and surveillance toolsIoannis Parodis, Mariele Gatto, Christopher Sjöwall
The Journal of Rheumatology|November 15, 2023
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus ErythematosusZahi Touma, Ioannis Parodis, Vibeke Strand
Current Opinion in Rheumatology|January 11, 2022
Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insightsJulius Lindblom, Chandra Mohan, Ioannis Parodis
Rheumatology (Oxford, England)|January 12, 2024
Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumabSandra Jägerback, Alvaro Gomez, Ioannis Parodis
Brain Sciences|February 25, 2022
Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last DecadeJulius Lindblom, Chandra Mohan, Ioannis Parodis
Frontiers in Medicine|August 6, 2020
B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical PracticeIoannis Parodis, Marit Stockfelt, Christopher Sjöwall
Patient Related Outcome Measures|January 26, 2023
Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World EvidenceAlvaro Gomez, Yvonne Enman, Ioannis Parodis
Rheumatology International|March 7, 2024
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional studyAlvaro Gomez, Ioannis Parodis, Christopher Sjöwall
Pageof 19